Detalles de la búsqueda
1.
Microfluidic Isolation of Disseminated Tumor Cells from the Bone Marrow of Breast Cancer Patients.
Int J Mol Sci
; 24(18)2023 Sep 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37762233
2.
HCC biomarkers - state of the old and outlook to future promising biomarkers and their potential in everyday clinical practice.
Front Oncol
; 12: 1016952, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36518320
3.
Beneficial modulation of the tumor microenvironment and generation of anti-tumor responses by TLR9 agonist lefitolimod alone and in combination with checkpoint inhibitors.
Oncoimmunology
; 8(12): e1659096, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31741757
4.
EnanDIM - a novel family of L-nucleotide-protected TLR9 agonists for cancer immunotherapy.
J Immunother Cancer
; 7(1): 5, 2019 01 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30621769
5.
Design and characterization of the tumor vaccine MGN1601, allogeneic fourfold gene-modified vaccine cells combined with a TLR-9 agonist.
Mol Ther Oncolytics
; 3: 15023, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27119114
6.
MIDGE Technology for the Production of a Fourfold Gene-Modified, Allogenic Cell-Based Vaccine for Cancer Therapy.
Methods Mol Biol
; 1317: 39-51, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26072400
Resultados
1 -
6
de 6
1
Próxima >
>>